Back to search
FDAFDA · Food and drugs·Recall number Z-2190-2021

HeartWare HVAD Pump Implant Kit, REF 1125

Published August 18, 2021 · Recall initiated: June 3, 2021

Summary

FDA records medical device Class I recall Z-2190-2021, published August 18, 2021 and initiated June 3, 2021. Recalling firm: Heartware, Inc.; Status: Ongoing; Reported quantity: 4078 units; Lot: GTIN: 00888707000222, 00888707007641, 00888707005685 All serial numbers. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Medtronic is stopping the distribution and sale of the HVAD System due to a growing body of observational clinical comparisons that shows a higher frequency of neurological adverse events and mortality associated with the system when compared to other commercially available left ventricular assist devices, as well as complaints that the internal pump may delay or fail to restart.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Heartware, Inc.
Distributor
Worldwide distribution. US nationwide and Armenia, AUSTRIA, Bahrain, Belgium, CROATIA, CZECH REPUBLIC, Denmark, EGYPT, ESTONIA, FINLAND, FRANCE, GERMANY, GREECE, Hungary, Israel, ITALY, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, LITHUANIA, LUXEMBOURG, Macedonia, NETHERLANDS, Norway, POLAND, Qatar, Romania, SAUDI ARABIA, Serbia, Slovakia, SOUTH AFRICA, Spain, Sweden, SWITZERLAND, TAIWAN, Turkey, Ukraine, UNITED ARAB EMIRATES, and United Kingdom.
Lot
GTIN: 00888707000222, 00888707007641, 00888707005685 All serial numbers
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was HeartWare HVAD Pump Implant Kit, REF 1125 recalled?

Yes. FDA published recall Z-2190-2021 on August 18, 2021. Reported hazard: Medtronic is stopping the distribution and sale of the HVAD System due to a growing body of observational clinical comparisons that shows a higher frequency of neurological adverse events and mortality associated with the system when compared to other commercially available left ventricular assist devices, as well as complaints that the internal pump may delay or fail to restart.

What should I do if I have this product?

Voluntary: Firm initiated · Letter